CTC Bio Inc. (060590) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for CTC Bio Inc. (060590:KRX), powered by AI.

Current Price
₩3,260
P/E Ratio
24.3
Market Cap
78.8B
Sector
Healthcare
What is the CTC Bio Inc. stock price forecast?

CTC Bio Inc. is currently trading at ₩3,260. View real-time AI analysis on Alpha Lenz.

What is CTC Bio Inc. insider trading activity?

View the latest insider trading data for CTC Bio Inc. on Alpha Lenz.

What is CTC Bio Inc.'s P/E ratio?

CTC Bio Inc.'s P/E ratio is 24.3.

CTC Bio Inc.

KRX · 060590
₩3,260+60(+1.88%)Market closedKRX regular session 09:00–15:30 KST
Ask about CTC Bio Inc.'s future dividend policy...
Alpha Chat Insight

CTC Bio Inc. trades at a P/E of 24.3 (fair value) with modest ROE of 4.6%.

Ask for details

Company Overview

CTC Bio Inc. is a biotechnology and pharmaceutical company specializing in the development of health-related products. Its primary function is to advance healthcare solutions through innovative research and development in biotechnology and pharmaceuticals. CTC Bio Inc. focuses on creating products that address diverse medical needs, including dietary supplements, pharmaceuticals, and bio-healthcare products. The company's influence is significant in sectors such as healthcare, nutrition, and pharmaceuticals, where it plays a role in improving human health and wellness. CTC Bio's operations contribute to the growing field of biotechnology, reflecting the increasing demand for advanced medical and health solutions. Within the financial market, CTC Bio Inc. holds an essential position by pushing forward the boundaries of medical science and responding to modern healthcare challenges. The company is noted for its commitment to quality and effective health solutions, positioning itself as a key player in the South Korean and global biotechnology landscape.

CEO조창선, 김신규(공동대표이사)
SectorHealthcare
IndustryBiotechnology
Employees248

Company Statistics

FY 2025

Profile

₩78,830,125,200Market Cap
₩123,769,377,290Revenue
24.18MShares Out
248Employees

Margins

40.65%Gross
9.56%EBITDA
5.05%Operating
2.41%Pre-Tax
2.62%Net

Valuation

24.33P/E
1.08P/B
0.64EV/Sales
8.52EV/EBITDA
22.80P/FCF

Growth (CAGR)

-9.18%Rev 3Yr
-0.98%Rev 5Yr
-17.75%Op Inc 3Yr
N/AOp Inc 5Yr
-11.68%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

2.18%ROA
4.55%ROE
3.57%ROIC

Financial Health

₩16,750,602,540Cash & Cash Equivalents
₩53,761,054,740Net Debt
96.96%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

CTC Bio Inc. (ticker: 060590) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 248 employees. Market cap is $78.8B.

The current price is ₩3,260 with a P/E ratio of 24.33x and P/B of 1.08x.

ROE is 4.55% and operating margin is 5.05%. Annual revenue is $123.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
CTC Bio Inc. (060590) Stock Forecast 2026 ₩3,260 — Price, Financials & Analyst Targets | Alpha Lenz